CTSL and Parkinson disease: In vitro neuroprotection by a cathepsin L inhibitor has recently been demonstrated in a SH-SY5Y cell model of PD, where an irreversible cathepsin L inhibitor, Z-FY(t-Bu)-DMK, significantly reduces 6-OHDA-induced apoptosis [33].